AHCO AdaptHealth Corp.
$6.06▲ +3.59%
Healthcare
Other
After hours
$6.06▲ +0.00%
Sep 11, 7:30 PM ET
Volume 2.08M
Avg Volume (10D) 2.82M
Key Metrics & Fundamentals
Market Cap
$808.46M
P/E Ratio
–
Div Yield
–%
52W Range
5.21 - 13.43
% vs 50 MA
-23.81%
% vs 200 MA
-38.88%
RSI-14
43.8
MACD Histogram
+0.1900
Beta (1Y vs SPY)
0.06
Free Cash Flow
-$20.94M
Gross Rev
$567.53M
Gross Profit
-$68.57M
EBITDA
$120.46M
COGS
$636.10M
Operating Exp
-$68.73M
Operating Income
$165,000
EBIT
$165,000
Pretax Income
-$165.33M
Net Income
-$133.93M
EPS (Diluted)
-0.99
Price & Volume History
Loading chart…
Recent News

AdaptHealth To Participate in Upcoming Investor Conferences
Business Wire · Sep 11, 2026 5:00 PM

Why AdaptHealth (AHCO) Stock Is Down Today
StockStory · Sep 9, 2026 6:10 PM
AdaptHealth Names Chief Financial Officer
MT Newswires · Sep 8, 2026 8:36 PM
AdaptHealth Appoints Harriss Currie as Chief Financial Officer
Business Wire · Sep 8, 2026 8:00 PM

Senior Health, Home Health & Hospice Stocks Q2 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO)
StockStory · Sep 1, 2026 6:58 PM

ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health
PR Newswire · Aug 17, 2026 1:00 PM

1 Cash-Producing Stock to Consider Right Now and 2 Facing Challenges
StockStory · Aug 16, 2026 9:49 AM

3 of Wall Street’s Favorite Stocks That Fall Short
StockStory · Aug 16, 2026 12:05 AM

5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call
StockStory · Aug 13, 2026 3:17 AM

AdaptHealth (AHCO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 4:44 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AHCO's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.